A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Reinier C A van Linschoten(Erasmus MC), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Bas Oldenburg(University Medical Center Utrecht), Marieke Pierik(Maastricht University Medical Centre), Annemarie C. de Vries(Erasmus MC), Frank Hoentjen(Radboud University Nijmegen), Rosalie C. Mallant–Hent, Alexander Bodelier(Amphia Ziekenhuis), Sita Jansen(Reinier de Graaf Hospital), Andrea E. van der Meulen‐de Jong(Leiden University Medical Center), Wietske Kievit(Radboud University Nijmegen), Frank H.J. Wolfhagen(Albert Schweitzer Ziekenhuis), Maurice Lutgens(Elisabeth-TweeSteden Ziekenhuis), Fenna M. Jansen(Radboud University Nijmegen), R Pauwels(Erasmus MC), Femke Atsma(Radboud University Nijmegen), Dirk J. de Jong(Radboud University Nijmegen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), C. Janneke van der Woude(Radboud University Nijmegen), Paul J. Boekema(Radboud University Nijmegen), Lisa Smits(Radboud University Nijmegen), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Adrianus Tan(Canisius-Wilhelmina Ziekenhuis), Ingrid Gisbertz(Ziekenhuis Bernhoven), Pieter C. J. ter Borg(Ikazia Ziekenhuis), Nanne K.H. de Boer, Maurice G. Rüssel(Medisch Spectrum Twente)
Cited by 2
Related Papers
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478